Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...
CHICAGO — Alcohol-related cirrhosis carries a twofold higher mortality risk than cirrhosis stemming from metabolic dysfunction-associated steatohepatitis, even when disease severity is matched, noted ...
Portal hypertension (PHT) is a severe complication of chronic liver disease, like cirrhosis, where increased pressure builds up in the portal vein. This major blood vessel drains blood from the ...
Portal hypertension (PH) represents a pivotal challenge in the clinical management of hepatocellular carcinoma (HCC), as both conditions commonly coexist on a background of cirrhosis. Elevated ...
Genkyotex, société biopharmaceutique leader des thérapies de traitement des enzymes NOX, a annoncé la publication de données dans Clinics and Research in Hepatology and Gastroenterology, montrant que ...
Portal hypertensive gastropathy (PHG) is often seen in patients with portal hypertension, and can lead to transfusion-dependent anemia as well as acute, life-threatening bleeding episodes. This Review ...
Dr Filip Janssens: “L’hypertension portale se définit par une augmentation de la pression sanguine dans la veine porte du foie. La veine porte fournit 75 % du sang au foie, en transportant le sang de ...
L'étude a démontré que lanifibranor améliorait l'hypertension portale (HTP) dans des modèles murins d'HTP fibrotique et d'HTP non fibrotique préhépatique Il a été observé que lanifibranor réduit la ...
The liver serves many critical functions within the human body, including the production of critical proteins, and the removal of waste and toxins. But when damage occurs to the largest organ in the ...
Consacrée à une technique ou à un ensemble de techniques pour une pathologie ou une région anatomique les volumes de la collection ' Techniques chirurgicales ' décrivent pas à pas les techniques en ...
(Boursier.com) — Genkyotex , société biopharmaceutique leader des thérapies de traitement des enzymes NOX, a annoncé la publication de données dans Clinics and Research in Hepatology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results